查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1954364

滑鼠模型市場分析及預測（至2035年）：依類型、產品類型、服務、技術、應用、組件、最終用戶、功能、設備分類

Mice Model Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Component, End User, Functionality, Device
出版日期: | 出版商: Global Insight Services | 英文 361 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計小鼠模型市場將從2024年的15億美元成長到2034年的40億美元，複合年成長率約為9.5%。小鼠模型市場涵蓋基因工程小鼠在生物醫學研究中的開發和應用，主要集中在疾病建模、藥物發現和安全性測試方面。這些模型為人類疾病的研究提供了重要見解，並推動了個人化醫療和治療性介入的發展。隨著慢性病發病率的上升和對創新治療方法需求的不斷成長，基因編輯技術的進步和研發投入的增加預計將顯著推動該市場的成長。

受基因工程技術的進步和臨床前研究需求的不斷成長的推動，小鼠模型市場正經歷強勁成長。基因改造小鼠主導市場，其中基因敲除小鼠和基因轉殖小鼠作為關鍵細分市場表現出色，這主要得益於效用。近交系小鼠緊隨其後，因其遺傳穩定性和研究可靠性而備受青睞。包括小鼠繁殖和冷凍保存在內的相關服務正在蓬勃發展，為客製化模型的日益普及提供了支持。由於人源化小鼠模型具有提升轉化研究成果的潛力，人們對這類模型的興趣顯著增加。此外，先進的表現型分析技術也正在興起，以提高數據準確性和研究效率。隨著個人化醫療和標靶治療的不斷發展，對專業小鼠模型的需求預計將持續成長，為市場參與企業帶來盈利的機會。注重倫理研究實踐和遵守監管規定仍然是實現永續成長的關鍵。

市場區隔
類型 近交系小鼠、基因工程小鼠、條件反射小鼠、遠交系小鼠、雜交小鼠、自發性突變小鼠
產品 小鼠模型、小鼠胚胎及小鼠相關服務
服務 繁殖服務、冷凍保存、檢疫服務、基因檢測
科技 CRISPR/Cas9、TALENs、鋅指核酸酶
應用領域 腫瘤學、心血管研究、神經科學、免疫學、感染疾病、糖尿病研究
成分 活體小鼠、冷凍胚胎和組織樣本
最終用戶 製藥公司、生技公司、研究機構、受託研究機構
功能 基因表現、表現型分析、行為分析
裝置 籠具、餵料系統及監測設備

在小鼠模型市場，市場佔有率由少數主要企業主導，定價策略也反映了市場對專業化模型的高需求。近期產品推出主要集中在先進的基因改造技術，以滿足科學研究應用中對更高精度日益成長的需求。各公司都致力於透過獨特的產品和增強的功能來實現差異化，這充分體現了他們對創新的高度重視。小鼠模型在藥物研發和生物醫學研究中的日益普及進一步加劇了這種競爭格局。競爭基準研究凸顯了市場環境的動態性，主要企業都在努力維持自身優勢，市場環境也不斷變化。監管因素，尤其是在北美和歐洲，透過制定嚴格的倫理使用和繁殖標準，在塑造市場動態發揮關鍵作用。這些法規影響市場參與企業的營運策略，並推動合規和創新。該市場擁有大量在研舉措，預示著其健康的成長前景和為相關人員帶來的成長機會。

主要趨勢和促進因素：

受基因工程技術的進步以及腫瘤學和免疫學領域研究的不斷深入推動，小鼠模型市場正經歷強勁成長。其中一個關鍵趨勢是人源化小鼠模型的開發，這對於研究人類特異性疾病和藥物反應至關重要。這些模型正成為轉化研究的重要工具，彌合了實驗室研究結果與臨床應用之間的鴻溝。對個人化醫療的需求也是關鍵促進因素，推動了對能夠模擬個別基因譜的客製化小鼠模型的需求。這一趨勢正在加速精準醫療研究，並促成更具針對性和更有效的治療性介入。此外，受託研究機構（CRO）的興起使中小型生物技術公司也能更便捷地獲得先進的小鼠模型，從而普及了研究能力。同時，倫理考量和法規結構也在重塑市場格局，推動替代方法的發展和現有模型的改進。新興市場蘊藏著許多機遇，這些市場的研究基礎設施正在不斷完善，生物醫學研究投資也持續成長。那些在模型建構方面不斷創新並提供全面支援服務的公司，將更有機會在這個不斷發展的市場中佔據重要佔有率。

目錄

第1章執行摘要

第2章 市場亮點

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章 細分市場分析

  • 市場規模及預測：依類型
    • 近交系小鼠
    • 基因工程小鼠
    • 條件反射小鼠
    • 非近交系小鼠
    • 混合小鼠
    • 自發突變小鼠
  • 市場規模及預測：依產品分類
    • 小鼠模型
    • 小鼠胚胎
    • 滑鼠相關服務
  • 市場規模及預測：依服務分類
    • 繁殖服務
    • 冷凍保存
    • 隔離服務
    • 基因檢測
  • 市場規模及預測：依技術分類
    • CRISPR/Cas9
    • TALENs
    • 鋅指核酸酶
  • 市場規模及預測：依應用領域分類
    • 腫瘤學
    • 心血管研究
    • 神經科學
    • 免疫學
    • 感染疾病
    • 糖尿病調查
  • 市場規模及預測：依組件分類
    • 活鼠
    • 冷凍胚胎
    • 組織樣本
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 生技公司
    • 研究所
    • 合約研究機構
  • 市場規模及預測：依功能分類
    • 基因表現
    • 表現型分析
    • 行為分析
  • 市場規模及預測：依設備分類
    • 籠
    • 餵料系統
    • 監測設備

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地區
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 台灣
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他歐洲地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 撒哈拉以南非洲
    • 其他中東和非洲地區

第6章 市場策略

  • 需求與供給差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 法規概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章 公司簡介

  • The Jackson Laboratory
  • Taconic Biosciences
  • Charles River Laboratories
  • Envigo
  • Janvier Labs
  • Gen Oway
  • Harlan Laboratories
  • Horizon Discovery
  • Ingenious Targeting Laboratory
  • Cyagen Biosciences
  • Trans Genic
  • Phoenix Bio
  • Crown Bioscience
  • Ozgene
  • Biocytogen
  • Shanghai Model Organisms
  • Gem Pharmatech
  • Vitalstar Biotechnology
  • In Vivos
  • Yecuris

第9章：關於我們

簡介目錄
Product Code: GIS24142

Mice Model Market is anticipated to expand from $1.5 billion in 2024 to $4.0 billion by 2034, growing at a CAGR of approximately 9.5%. The Mice Model Market encompasses the development and utilization of genetically engineered mice for biomedical research, focusing on disease modeling, drug discovery, and safety testing. These models provide critical insights into human diseases, enabling advancements in personalized medicine and therapeutic interventions. With the rise in chronic diseases and demand for innovative treatments, the market is poised for significant growth, driven by technological advancements in gene editing and increasing investment in R&D.

The Mice Model Market is experiencing robust growth, fueled by advancements in genetic engineering and increasing demand for preclinical research. Genetically modified mice dominate the market, with knockout and transgenic mice being top-performing sub-segments, due to their utility in disease modeling and drug discovery. Inbred mice follow as the second highest performing segment, valued for their genetic consistency and reliability in research studies. The services segment, including breeding and cryopreservation, is gaining momentum, supporting the expanding use of customized models. Rising interest in humanized mice models is notable, driven by their potential to enhance translational research outcomes. Furthermore, the market is witnessing a shift towards advanced phenotyping technologies, improving data accuracy and research efficiency. As personalized medicine and targeted therapies continue to evolve, the demand for specialized mouse models is expected to rise, presenting lucrative opportunities for market participants. The emphasis on ethical research practices and regulatory compliance remains critical to sustainable growth.

Market Segmentation
TypeInbred Mice, Genetically Engineered Mice, Conditioned Mice, Outbred Mice, Hybrid Mice, Spontaneous Mutant Mice
ProductMouse Models, Mouse Embryos, Mouse Services
ServicesBreeding Services, Cryopreservation, Quarantine Services, Genetic Testing
TechnologyCRISPR/Cas9, TALENs, Zinc Finger Nucleases
ApplicationOncology, Cardiovascular Studies, Neuroscience, Immunology, Infectious Diseases, Diabetes Research
ComponentLive Mice, Frozen Embryos, Tissue Samples
End UserPharmaceutical Companies, Biotechnology Firms, Research Institutes, Contract Research Organizations
FunctionalityGene Expression, Phenotypic Analysis, Behavioral Analysis
DeviceCages, Feeding Systems, Monitoring Equipment

In the Mice Model Market, market share is largely dominated by a few key players, with pricing strategies reflecting the high demand for specialized models. Recent product launches have focused on advanced genetic modifications, catering to the growing need for precision in research applications. The emphasis on innovation is evident, as companies strive to differentiate through unique offerings and enhanced capabilities. This competitive landscape is further fueled by the increasing utilization of mice models in drug development and biomedical research. Competition benchmarking reveals a dynamic environment where leading firms are constantly evolving to maintain their edge. Regulatory influences, particularly in North America and Europe, play a pivotal role in shaping market dynamics, setting stringent standards for ethical use and breeding practices. These regulations impact the operational strategies of market participants, driving compliance and innovation. The market is characterized by a robust pipeline of research initiatives, indicating a healthy trajectory of growth and opportunity for stakeholders.

Geographical Overview:

The Mice Model Market is witnessing diverse growth patterns across various regions, each presenting unique opportunities. North America leads the market, driven by advanced research facilities and substantial funding in biomedical research. The region's robust infrastructure for genetic engineering and translational research further propels its dominance. Europe follows, with strong governmental support for healthcare research and increasing demand for personalized medicine. Asia Pacific is experiencing rapid growth, fueled by rising investments in biotechnology and expanding pharmaceutical industries. The region's focus on innovative research and development enhances its market potential. Within this landscape, China and India are emerging as key players, leveraging their vast pools of scientific talent and government initiatives. Latin America and the Middle East & Africa are also gaining traction. In Latin America, growing interest in biopharmaceutical research is evident, while the Middle East & Africa are recognizing the importance of advanced research models to boost healthcare innovation.

The global tariff landscape and geopolitical risks are significantly influencing the Mice Model Market, particularly in Japan, South Korea, China, and Taiwan. Japan and South Korea are pivoting towards enhancing domestic research capabilities to mitigate tariff-induced cost pressures on imported laboratory models. China's strategic focus is on self-sufficiency in biomedical research tools amid trade tensions, while Taiwan leverages its advanced biotech sector to maintain competitive advantage. The global market for mice models is thriving, driven by rising demand in biomedical research and drug development. By 2035, the market is poised for robust growth, contingent on geopolitical stability and innovation in genetic engineering. Middle East conflicts could disrupt global supply chains and elevate energy prices, indirectly affecting operational costs and research timelines in this sector.

Key Trends and Drivers:

The Mice Model Market is experiencing robust growth driven by advancements in genetic engineering and increased research in oncology and immunology. A key trend is the development of humanized mice models, which are pivotal for studying human-specific diseases and drug responses. These models are becoming essential tools in translational research, bridging the gap between laboratory findings and clinical applications. The demand for personalized medicine is another significant driver, pushing the need for tailor-made mice models that mimic individual genetic profiles. This trend is accelerating research in precision medicine, enabling more targeted and effective therapeutic interventions. Additionally, the rise of contract research organizations (CROs) is facilitating access to sophisticated mice models for smaller biotech firms, democratizing research capabilities. Moreover, ethical considerations and regulatory frameworks are shaping the market landscape, encouraging the development of alternative methods and refinement of existing models. Opportunities abound in emerging markets where research infrastructure is expanding, and investments in biomedical research are increasing. Companies that innovate in model creation and offer comprehensive support services are well-positioned to capture a significant share of this evolving market.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Component
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Device

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Inbred Mice
    • 4.1.2 Genetically Engineered Mice
    • 4.1.3 Conditioned Mice
    • 4.1.4 Outbred Mice
    • 4.1.5 Hybrid Mice
    • 4.1.6 Spontaneous Mutant Mice
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Mouse Models
    • 4.2.2 Mouse Embryos
    • 4.2.3 Mouse Services
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Breeding Services
    • 4.3.2 Cryopreservation
    • 4.3.3 Quarantine Services
    • 4.3.4 Genetic Testing
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 CRISPR/Cas9
    • 4.4.2 TALENs
    • 4.4.3 Zinc Finger Nucleases
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Oncology
    • 4.5.2 Cardiovascular Studies
    • 4.5.3 Neuroscience
    • 4.5.4 Immunology
    • 4.5.5 Infectious Diseases
    • 4.5.6 Diabetes Research
  • 4.6 Market Size & Forecast by Component (2020-2035)
    • 4.6.1 Live Mice
    • 4.6.2 Frozen Embryos
    • 4.6.3 Tissue Samples
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Biotechnology Firms
    • 4.7.3 Research Institutes
    • 4.7.4 Contract Research Organizations
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Gene Expression
    • 4.8.2 Phenotypic Analysis
    • 4.8.3 Behavioral Analysis
  • 4.9 Market Size & Forecast by Device (2020-2035)
    • 4.9.1 Cages
    • 4.9.2 Feeding Systems
    • 4.9.3 Monitoring Equipment

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Component
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Device
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Component
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Device
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Component
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Device
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Component
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Device
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Component
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Device
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Component
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Device
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Component
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Device
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Component
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Device
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Component
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Device
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Component
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Device
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Component
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Device
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Component
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Device
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Component
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Device
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Component
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Device
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Component
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Device
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Component
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Device
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Component
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Device
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Component
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Device
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Component
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Device
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Component
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Device
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Component
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Device
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Component
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Device
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Component
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Device
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Component
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Device

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 The Jackson Laboratory
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Taconic Biosciences
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Charles River Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Envigo
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Janvier Labs
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Gen Oway
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Harlan Laboratories
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Horizon Discovery
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Ingenious Targeting Laboratory
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Cyagen Biosciences
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Trans Genic
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Phoenix Bio
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Crown Bioscience
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Ozgene
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Biocytogen
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Shanghai Model Organisms
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Gem Pharmatech
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Vitalstar Biotechnology
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 In Vivos
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Yecuris
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us